Triethylamine → HCID 178502905, compound
Reaction equation
[Cl:1][C:2]1[CH:23]=[CH:22][C:5]2[NH:6][C:7]([CH:9]3[CH2:12][N:11]([C:13]4N=CC=[CH:18][C:14]=4[C:15](O)=[O:16])[CH2:10]3)=[N:8][C:4]=2[CH:3]=1.[NH:24]1C[CH:26]([OH:28])[CH2:25]1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(CC)CC.C([O-])([O-])=O.[Na+].[Na+]>C(Cl)Cl>[Cl:1][C:2]1[CH:23]=[CH:22][C:5]2[NH:6][C:7]([C:9]3([CH:10]4[CH:26]([OH:28])[CH2:25][NH:24]4)[CH:18]=[CH:14][CH:13]=[N:11][CH2:12]3)=[N:8][C:4]=2[CH:3]=1.[CH2:15]=[O:16]Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 2-[3-(5-chloro-1H-benzoimidazol-2-yl)-azetidin-1-yl]-nicotinic acid (100 mg, 0.30 mmol), azetidin-3-ol (200 mg, 2.73 mmol), HATU (347 mg, 0.9 mmol), and Et3N (101 mg, 1 mmol) in dry DCM (10 mL) was stirred at RT overnight. The mixture was then poured into saturated aqueous Na2CO3. The organic layer was washed with brine, dried over Na2SO4 and concentrated to give the crude compound which was purified by column chromatography and followed by preparative HPLC to afford pure product {2-[3-(5-chloro-1H-benzoimidazol-2-yl]-pyridin-3-yl}-(3-hydroxy-azetidin)-methanone (30 mg, yield 30%). [M+1] 384. IC50 (uM) 0.549.
Workup
- washThe organic layer was washed with brine
- dry with materialdried over Na2SO4
- concentrationconcentrated
- customto give the crude compound which
- customwas purified by column chromatography
Sources & evidence
- ORD record
- ord-905fbf55526d4989a5d35e9fadfaa013
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08946230B2
Reaction notes
Loading…